Utah Medical Products Net Income
| UTMD Stock | USD 66.84 0.33 0.50% |
As of the 4th of March, Utah Medical has the Coefficient Of Variation of 499.91, semi deviation of 1.09, and Risk Adjusted Performance of 0.1554. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Utah Medical Products, as well as the relationship between them. Please validate Utah Medical Products treynor ratio, and the relationship between the standard deviation and downside variance to decide if Utah Medical is priced more or less accurately, providing market reflects its prevalent price of 66.84 per share. Given that Utah Medical Products has jensen alpha of 0.2569, we advise you to double-check Utah Medical Products's current market performance to make sure the company can sustain itself at a future point.
Utah Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 3.3306 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 11.3 M | 10.3 M | |
| Net Income Applicable To Common Shares | 18.9 M | 11.8 M | |
| Net Income From Continuing Ops | 16 M | 16.7 M | |
| Net Income Per Share | 3.41 | 3.58 | |
| Net Income Per E B T | 0.80 | 0.58 |
Utah | Net Income | Build AI portfolio with Utah Stock |
Analyzing Utah Medical's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Utah Medical's current valuation and future prospects.
Latest Utah Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Utah Medical Products over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Utah Medical Products financial statement analysis. It represents the amount of money remaining after all of Utah Medical Products operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Utah Medical's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Utah Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 11.29 M | 10 Years Trend |
|
Net Income |
| Timeline |
Utah Net Income Regression Statistics
| Arithmetic Mean | 11,778,564 | |
| Geometric Mean | 9,926,625 | |
| Coefficient Of Variation | 35.57 | |
| Mean Deviation | 2,916,881 | |
| Median | 11,406,000 | |
| Standard Deviation | 4,189,406 | |
| Sample Variance | 17.6T | |
| Range | 18.2M | |
| R-Value | 0.54 | |
| Mean Square Error | 13.2T | |
| R-Squared | 0.30 | |
| Significance | 0.02 | |
| Slope | 450,776 | |
| Total Sum of Squares | 280.8T |
Utah Net Income History
Other Fundumenentals of Utah Medical Products
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Utah Medical Net Income component correlations
Utah Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Utah Medical is extremely important. It helps to project a fair market value of Utah Stock properly, considering its historical fundamentals such as Net Income. Since Utah Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Utah Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Utah Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Utah diversify its offerings? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Utah Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.06) | Dividend Share 1.225 | Earnings Share 3.45 | Revenue Per Share | Quarterly Revenue Growth (0.01) |
Utah Medical Products's market price often diverges from its book value, the accounting figure shown on Utah's balance sheet. Smart investors calculate Utah Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Utah Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Utah Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Utah Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Utah Medical.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in Utah Medical on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding Utah Medical Products or generate 0.0% return on investment in Utah Medical over 90 days. Utah Medical is related to or competes with Nyxoah, OraSure Technologies, Repro Med, InfuSystems Holdings, Neuronetics, Perspective Therapeutics, and Protalix Biotherapeutics. Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry More
Utah Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Utah Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Utah Medical Products upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.37 | |||
| Information Ratio | 0.1667 | |||
| Maximum Drawdown | 5.59 | |||
| Value At Risk | (1.94) | |||
| Potential Upside | 2.29 |
Utah Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Utah Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Utah Medical's standard deviation. In reality, there are many statistical measures that can use Utah Medical historical prices to predict the future Utah Medical's volatility.| Risk Adjusted Performance | 0.1554 | |||
| Jensen Alpha | 0.2569 | |||
| Total Risk Alpha | 0.2021 | |||
| Sortino Ratio | 0.1707 | |||
| Treynor Ratio | 0.7219 |
Utah Medical March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1554 | |||
| Market Risk Adjusted Performance | 0.7319 | |||
| Mean Deviation | 1.16 | |||
| Semi Deviation | 1.09 | |||
| Downside Deviation | 1.37 | |||
| Coefficient Of Variation | 499.91 | |||
| Standard Deviation | 1.4 | |||
| Variance | 1.97 | |||
| Information Ratio | 0.1667 | |||
| Jensen Alpha | 0.2569 | |||
| Total Risk Alpha | 0.2021 | |||
| Sortino Ratio | 0.1707 | |||
| Treynor Ratio | 0.7219 | |||
| Maximum Drawdown | 5.59 | |||
| Value At Risk | (1.94) | |||
| Potential Upside | 2.29 | |||
| Downside Variance | 1.88 | |||
| Semi Variance | 1.18 | |||
| Expected Short fall | (1.23) | |||
| Skewness | (0.1) | |||
| Kurtosis | (0.49) |
Utah Medical Products Backtested Returns
Utah Medical appears to be very steady, given 3 months investment horizon. Utah Medical Products owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.22, which indicates the firm had a 0.22 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Utah Medical Products, which you can use to evaluate the volatility of the company. Please review Utah Medical's Semi Deviation of 1.09, coefficient of variation of 499.91, and Risk Adjusted Performance of 0.1554 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Utah Medical holds a performance score of 17. The entity has a beta of 0.38, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Utah Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Utah Medical is expected to be smaller as well. Please check Utah Medical's downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Utah Medical's existing price patterns will revert.
Auto-correlation | 0.67 |
Good predictability
Utah Medical Products has good predictability. Overlapping area represents the amount of predictability between Utah Medical time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Utah Medical Products price movement. The serial correlation of 0.67 indicates that around 67.0% of current Utah Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.67 | |
| Spearman Rank Test | 0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 5.2 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Utah Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Utah Medical Products reported net income of 11.29 M. This is 96.69% lower than that of the Health Care Equipment & Supplies sector and 88.67% lower than that of the Health Care industry. The net income for all United States stocks is 98.02% higher than that of the company.
Utah Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Utah Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Utah Medical could also be used in its relative valuation, which is a method of valuing Utah Medical by comparing valuation metrics of similar companies.Utah Medical is currently under evaluation in net income category among its peers.
Utah Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Utah Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Utah Medical's managers, analysts, and investors.Environmental | Governance | Social |
Utah Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Utah Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Utah Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Utah Medical's value.| Shares | Bank Of New York Mellon Corp | 2025-09-30 | 45.5 K | Isthmus Partners Llc | 2025-09-30 | 38.3 K | Huber Capital Management Llc | 2025-12-31 | 36.8 K | Northern Trust Corp | 2025-09-30 | 31.4 K | Cardinal Capital Management | 2025-12-31 | 24.8 K | Quantinno Capital Management Lp | 2025-09-30 | 23 K | Bard Associates Inc | 2025-09-30 | 20.8 K | Millennium Management Llc | 2025-09-30 | 20.6 K | Everett Harris & Co | 2025-09-30 | 17.2 K | Brandes Investment Partners & Co | 2025-09-30 | 337.9 K | Dimensional Fund Advisors, Inc. | 2025-12-31 | 196.5 K |
Utah Fundamentals
| Return On Equity | 0.0954 | ||||
| Return On Asset | 0.0582 | ||||
| Profit Margin | 0.29 % | ||||
| Operating Margin | 0.31 % | ||||
| Current Valuation | 128.3 M | ||||
| Shares Outstanding | 3.19 M | ||||
| Shares Owned By Insiders | 7.17 % | ||||
| Shares Owned By Institutions | 69.46 % | ||||
| Number Of Shares Shorted | 104.31 K | ||||
| Price To Earning | 31.38 X | ||||
| Price To Book | 1.79 X | ||||
| Price To Sales | 5.53 X | ||||
| Revenue | 38.52 M | ||||
| Gross Profit | 22 M | ||||
| EBITDA | 17.06 M | ||||
| Net Income | 11.29 M | ||||
| Cash And Equivalents | 69.51 M | ||||
| Cash Per Share | 19.17 X | ||||
| Total Debt | 3.27 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 13.44 X | ||||
| Book Value Per Share | 37.43 X | ||||
| Cash Flow From Operations | 14.83 M | ||||
| Short Ratio | 8.35 X | ||||
| Earnings Per Share | 3.45 X | ||||
| Number Of Employees | 155 | ||||
| Beta | 0.32 | ||||
| Market Capitalization | 213.08 M | ||||
| Total Asset | 122.54 M | ||||
| Retained Earnings | 129.3 M | ||||
| Working Capital | 92.57 M | ||||
| Current Asset | 32.87 M | ||||
| Current Liabilities | 4.07 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.20 % | ||||
| Net Asset | 122.54 M | ||||
| Last Dividend Paid | 1.23 |
About Utah Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Utah Medical Products's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Utah Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Utah Medical Products based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:Check out You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Will Health Care Equipment & Supplies sector continue expanding? Could Utah diversify its offerings? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Utah Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.06) | Dividend Share 1.225 | Earnings Share 3.45 | Revenue Per Share | Quarterly Revenue Growth (0.01) |
Utah Medical Products's market price often diverges from its book value, the accounting figure shown on Utah's balance sheet. Smart investors calculate Utah Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Utah Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.